ºÝºÝߣshows by User: amymorgan21 / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: amymorgan21 / Wed, 14 May 2014 10:23:22 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: amymorgan21 Pricing strategy poland /slideshow/pricing-strategy-poland/34678027 pricingstrategypoland-140514102322-phpapp02
]]>
]]> Wed, 14 May 2014 10:23:22 GMT /slideshow/pricing-strategy-poland/34678027 amymorgan21@slideshare.net(amymorgan21) Pricing strategy poland amymorgan21 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pricingstrategypoland-140514102322-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Pricing strategy poland from Amy Morgan
]]> 331 4 https://cdn.slidesharecdn.com/ss_thumbnails/pricingstrategypoland-140514102322-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Hta in emerging markets /slideshow/hta-in-emerging-markets-34677863/34677863 htainemergingmarkets-140514101921-phpapp02
An overview of Health Technology Assessment (HTA) practices in selected Emerging markets]]>
An overview of Health Technology Assessment (HTA) practices in selected Emerging markets]]> Wed, 14 May 2014 10:19:21 GMT /slideshow/hta-in-emerging-markets-34677863/34677863 amymorgan21@slideshare.net(amymorgan21) Hta in emerging markets amymorgan21 An overview of Health Technology Assessment (HTA) practices in selected Emerging markets <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/htainemergingmarkets-140514101921-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> An overview of Health Technology Assessment (HTA) practices in selected Emerging markets
Hta in emerging markets from Amy Morgan
]]> 768 6 https://cdn.slidesharecdn.com/ss_thumbnails/htainemergingmarkets-140514101921-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Real time pcr market & end user needs survey /slideshow/real-time-pcr-market-end-user-needs-survey/12784413 realtimepcr-marketenduserneedssurvey-120503060556-phpapp02
]]>
]]> Thu, 03 May 2012 06:05:54 GMT /slideshow/real-time-pcr-market-end-user-needs-survey/12784413 amymorgan21@slideshare.net(amymorgan21) Real time pcr market & end user needs survey amymorgan21 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/realtimepcr-marketenduserneedssurvey-120503060556-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Real time pcr market & end user needs survey from Amy Morgan
]]> 4657 10 https://cdn.slidesharecdn.com/ss_thumbnails/realtimepcr-marketenduserneedssurvey-120503060556-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The healthcare, pharmaceutical & clinical trial environment in russia /slideshow/the-healthcare-pharmaceutical-clinical-trial-environment-in-russia/12669952 thehealthcarepharmaceuticalclinicaltrialenvironmentinrussia-120424090235-phpapp01
]]>
]]> Tue, 24 Apr 2012 09:02:33 GMT /slideshow/the-healthcare-pharmaceutical-clinical-trial-environment-in-russia/12669952 amymorgan21@slideshare.net(amymorgan21) The healthcare, pharmaceutical & clinical trial environment in russia amymorgan21 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/thehealthcarepharmaceuticalclinicaltrialenvironmentinrussia-120424090235-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
The healthcare, pharmaceutical & clinical trial environment in russia from Amy Morgan
]]> 340 2 https://cdn.slidesharecdn.com/ss_thumbnails/thehealthcarepharmaceuticalclinicaltrialenvironmentinrussia-120424090235-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Collaboration across the pharma enterprise /slideshow/collaboration-across-the-pharma-enterprise-12665578/12665578 collaborationacrossthepharmaenterprise-120424043213-phpapp02
This paper examines key success factors for effective collaboration in the pharmaceutical industry. In an industry where speed to market is critical and where informed and timely decisions can have large financial implications, collaboration is a key factor to ensure value is delivered. Consequently, considerable investment is being made by pharmaceutical companies to enable project teams to work more effectively together across departmental, functional, company and geographic boundaries. ]]>
This paper examines key success factors for effective collaboration in the pharmaceutical industry. In an industry where speed to market is critical and where informed and timely decisions can have large financial implications, collaboration is a key factor to ensure value is delivered. Consequently, considerable investment is being made by pharmaceutical companies to enable project teams to work more effectively together across departmental, functional, company and geographic boundaries. ]]> Tue, 24 Apr 2012 04:32:11 GMT /slideshow/collaboration-across-the-pharma-enterprise-12665578/12665578 amymorgan21@slideshare.net(amymorgan21) Collaboration across the pharma enterprise amymorgan21 This paper examines key success factors for effective collaboration in the pharmaceutical industry. In an industry where speed to market is critical and where informed and timely decisions can have large financial implications, collaboration is a key factor to ensure value is delivered. Consequently, considerable investment is being made by pharmaceutical companies to enable project teams to work more effectively together across departmental, functional, company and geographic boundaries. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/collaborationacrossthepharmaenterprise-120424043213-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> This paper examines key success factors for effective collaboration in the pharmaceutical industry. In an industry where speed to market is critical and where informed and timely decisions can have large financial implications, collaboration is a key factor to ensure value is delivered. Consequently, considerable investment is being made by pharmaceutical companies to enable project teams to work more effectively together across departmental, functional, company and geographic boundaries.
Collaboration across the pharma enterprise from Amy Morgan
]]> 1188 3 https://cdn.slidesharecdn.com/ss_thumbnails/collaborationacrossthepharmaenterprise-120424043213-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Pharmaceutics landscape /slideshow/pharmaceutics-landscape/12577483 pharmaceuticslandscape-120417142536-phpapp02
]]>
]]> Tue, 17 Apr 2012 14:25:34 GMT /slideshow/pharmaceutics-landscape/12577483 amymorgan21@slideshare.net(amymorgan21) Pharmaceutics landscape amymorgan21 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pharmaceuticslandscape-120417142536-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Pharmaceutics landscape from Amy Morgan
]]> 541 4 https://cdn.slidesharecdn.com/ss_thumbnails/pharmaceuticslandscape-120417142536-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 HTA in emerging markets /slideshow/hta-in-emerging-markets/12502027 htainemergingmarkets-120411105723-phpapp02
]]>
]]> Wed, 11 Apr 2012 10:57:21 GMT /slideshow/hta-in-emerging-markets/12502027 amymorgan21@slideshare.net(amymorgan21) HTA in emerging markets amymorgan21 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/htainemergingmarkets-120411105723-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
HTA in emerging markets from Amy Morgan
]]> 1410 6 https://cdn.slidesharecdn.com/ss_thumbnails/htainemergingmarkets-120411105723-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Market access the challenges for medical devices /slideshow/market-access-the-challenges-for-medical-devices/12501867 marketaccess-thechallengesformedicaldevices-120411104607-phpapp02
With increased incidences of reimbursement rejections by payers and a growing usage of pricing and reimbursement tools market access is becoming increasingly restricted… ]]>
With increased incidences of reimbursement rejections by payers and a growing usage of pricing and reimbursement tools market access is becoming increasingly restricted… ]]> Wed, 11 Apr 2012 10:46:05 GMT /slideshow/market-access-the-challenges-for-medical-devices/12501867 amymorgan21@slideshare.net(amymorgan21) Market access the challenges for medical devices amymorgan21 With increased incidences of reimbursement rejections by payers and a growing usage of pricing and reimbursement tools market access is becoming increasingly restricted… <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/marketaccess-thechallengesformedicaldevices-120411104607-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> With increased incidences of reimbursement rejections by payers and a growing usage of pricing and reimbursement tools market access is becoming increasingly restricted…
Market access the challenges for medical devices from Amy Morgan
]]> 5077 11 https://cdn.slidesharecdn.com/ss_thumbnails/marketaccess-thechallengesformedicaldevices-120411104607-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-amymorgan21-48x48.jpg?cb=1605710856 Marketing & strategy consultant with 15 years experience in healthcare, high technology and chemicals industries. PHARMACEUTICALS and BIOTECH - Market Access: reimbursement, payer profiles, payer environment research, pricing - Competitive intelligence and pricing analysis in pharma - Market Research: KoL interviewing, positioning, early stage drug commercial reviews - Therapeutic expertise: diabetes, neurology, mental health (depression, schizophrenia, anxiety), cardiovascular, oncology, dialysis, anti-infectives, gastro-intestinal, dermatology, virology/vaccines. - Nutraceutical market entry planning for EU CROs and R & D Suppliers - CROs and Laboratory business for pharma - Packagin... http://www.parioforma.com https://cdn.slidesharecdn.com/ss_thumbnails/pricingstrategypoland-140514102322-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/pricing-strategy-poland/34678027 Pricing strategy poland https://cdn.slidesharecdn.com/ss_thumbnails/htainemergingmarkets-140514101921-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/hta-in-emerging-markets-34677863/34677863 Hta in emerging markets https://cdn.slidesharecdn.com/ss_thumbnails/realtimepcr-marketenduserneedssurvey-120503060556-phpapp02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/real-time-pcr-market-end-user-needs-survey/12784413 Real time pcr market...